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ABSTRACT 
 RNase P is an endonuclease with a rare catalytic RNA core. The enzyme is a ribonucleoprotein 
(RNP) complex and is primarily responsible for cleaving the 5’ RNA leader sequence from precursor 
tRNA (ptRNA) molecules. The maturation of tRNA is necessary for all domains of life, which makes 
RNase P an indispensable and ubiquitous enzyme. This historical prevalence renders RNase P as a 
potential marker for evolution events. Early life forms like bacteria have very few RNase P Protein 
(RPP) cofactors; whereas later organisms like eukaryotes have been documented as having more than 
10 different protein cofactors. The increasing protein content has subsidized, diminishing RNase P 
RNA (RPR) content. Ongoing studies of RNase P aim to demonstrate how proteins have assumed 
biological responsibility from nucleic acids.  
 Our research focuses on the Archaeon Methanocaldococcus jannaschii (Mja). The Mja RNase P 
has five protein cofactors, two of which are RPP21 and RPP29. The conserved RPP21-RPP29 
heterodimer has been implicated in substrate recognition and binding events; however, the latter 
observation has yet to be applied to Eurkaryotes. Mja was chosen for our study because the RPR is 
very similar to eukaryotic RPR, and may help bridge the evolutionary gaps between bacteria and 
humans.  
 Using NMR spectroscopy, our objective is to deduce a solution structure of the RPP21-RPP29 
heterodimer. Our efforts have only extended so far as to express and purify both proteins and acquire 
NMR spectra for RPP29. I have been able to make predictions for the RPP29 secondary structure and 
have just begun to characterize protein binding; quaternary structure can't yet be determined. These 
data are a springboard for continuing research that will contribute to the discussion of evolution and 
protein-protein and protein-RNA interactions.   
 
 
INTRODUCTION 
RNase P Overview 
 In 1970, Sidney Altman discovered a unique enzyme that contained RNA and protein, but it 
wasn't until later that decade when serious shock-waves were felt around the scientific community [1]. 
By 1982, Altman's suspicions were confirmed [2], as RNase P became regarded as an exception to the 
central dogma of biology: RNA can perform catalysis. RNase P is ribonucleoprotein (RNP) complex 
which performs the essential step of cleaving of the 5' leader sequence from precursor tRNA (ptRNA) 
(Fig. 1.1)[3-5]. The RNP complex is found in all domains of life, and each homolog contains one 
catalytic RNA subunit (RNase P RNA, RPR) and variable numbers of protein subunits (RNase P 
Proteins, RPPs). In eubacteria, there is only one RPP, and in more highly evolved species—like 
humans—the RNase P complex contains at least nine protein subunits[6]. Interestingly, amidst the 
protein diversity, only the conserved RPR core retains catalytic activity [7, 8].    
  It is certain that archaeal and eukaryotic RPPs have adopted some functions specific to bacterial 
RPR [9], yet it is unclear why the RNA still remains. In vitro experiments have demonstrated that the 
RPR alone is sufficient for catalysis; however, catalytic activity in eukaryotic and some archaeal RPR 
can only be recovered under specific circumstances [10, 11], but even then, they have a slower turnover 
than bacterial homologs. In vivo, the RPPs are essential for catalysis [12]. Whether they mitigate some 
thermodynamic barrier or support the RNA tertiary structure [13-15], their role as a cofactor belies their 
vastly greater modularity and diversity over RNA. Adding more proteins to the RNP seems averse to 
Occam's razor. Our interest is in resolving why more proteins are found in more recently evolved 
species and discovering if there is evidence for diverging RPR structures being superseded for more 
modern protein-based biology.     
 Scrutiny of RNase P has revealed the molecule's breadth of activity. Besides processing tRNA, 
RNase P processes a variety of other ptRNA-like substrates [15-19] and regulates gene transcription  
[20]. In regard to human health, RNase P is an attractive antibiotic target because any disruption of the 
RNP complex inhibits enzymatic function [21].        
Bacterial RNase P 
  Bacterial RNase P is the simplest RNP configuration, one RPP cofactor and one large RPR [22]. 
The bacterial RPR can be classified into two types, type A (e.g. E. coli) and type B (e.g. B. subtillis) 
(Fig. 1.2) [22]. The RPR structures for both bacterial types have been reported by x-ray crystallography 
[23-26], and the RPP structures have been reported by crystallography and NMR [27, 28], but a high 
resolution structure of the holoenzyme has not yet been achieved. 
  Being the best studied, several general characteristics of RNase P have been extrapolated from 
bacterial forms. Namely, the RPR is composed of two domains, the C-domain and S-domain. The 
catalytic core is located on the C-domain, and when folded, it forms important intramolecular contacts 
with the S-domain [28]. The ptRNA cleavage reaction is performed by Mg2+-coordinated H2O 
molecule via a nucleophilic attack on a scissile phosodiester bond [29]. During this process, the 
conserved T stem loop of tRNA interacts the RPR S-domain [30], the tRNA acceptor stem interacts 
with the C-domain [31], and 3'-CCA (tRNA) base-pairs to the L15 region [32] (Fig.1.2).       
RNase P in higher organisms 
 In Archaea, RNase P is composed of at least four RPPs and one RPR, and like bacterial RNase 
P, the archaeal RPR is categorized in two distinct groups, type A (P. furiosus, Pfu) and type M (M. 
jannaschii, Mja)(Fig 1.2) [33, 34]. Type A closely resembles bacterial RPR, and type-M closely 
resembles eukaryotic RPR, from which it differs by two additional RNA regions. All RNRs from 
higher organisms are distinguishable from bacterial RNR by their deleted sequences [33]. Furthermore, 
the pattern of deleted RNA structural elements is consistent among archaeal and eukaryotic RNR types. 
It’s reasonable to propose that proteins were selected to replace lost RNA structure.  
Neither archaeal nor eukaryotic RPPs share sequence similarity to the bacterial RPP, however, 
evidence suggests that four of the archaeal RPPs share sequence similarity with human RPPs [33, 35]. 
The four archaeal proteins (RPP21-RPP29 and POP5-RPP30) form binary complexes prior to binding 
to the RNA [36], and each pair exerts some kinetic benefit upon the RNR. The structures of each of 
these four archaeal RPPs have been solved from various archaea with either X-ray crystallography or 
NMR. Not surprisingly, each structure contains familiar nucleic acid binding motifs: RPP21 contains a 
Zn (zinc) ribbon [37], RPP29 has an Sm-like fold (Sm protein) [38], RPP30 has a TIM-barrel (Triose-
phosphate isomerase) [37], and POP5 has an RRM-like fold (RNA recognition motif) [39].      
  Unlike the bacterial RPRs, in the absence of the proteins, M-type RPR can only perform 
catalysis under high ionic conditions and when the substrate is tethered in cis (Fig. 1.3) [11]. 
Reconstitution assays have shown that either binary complex is sufficient for archaeal RPR to process 
ptRNA, but no one RPP can elicit product turnover (Fig 1.4) [40]. Most notably, the POP5-RPP30 
complex significantly increases the Kconf, which is the equilibrium constant for the transition state 
conformations of RNase P-ptRNA. A similar rate enhancement is observed from RPP21-RPP29, but 
the effect is smaller. It is uncertain whether the eukaryotic RPP homologs have similar effects [41, 42].  
 Archaea are valuable model organisms because they provide a manageable system for 
understanding their eukaryotic homologs, which are often too complicated for detailed study. 
Extrapolations from bacterial RNase P may be less reliable because of the substantial differences 
between bacterial and eukaryal RNA and protein sequences. A structure for the free RPP21-RPP29 
complex has been published for Pfu [43], and if a structure could be solved for Mja, then it would be 
possible to generate testable hypotheses for how proteins have compensated for diminished RNA 
function (Fig 1.7). 
Methanocaldococcus Jannaschii 
 Interest in Mja RNase P stems from its unique RNR similarity to eukaryotic RNR. Additionally, 
there are similarities between RPPs (RPP21 is 34% similar to human homolgs and RPP29 is 20% 
similar to human homologs), though comprehensive comparisons to eurkayotic homologs are severely 
handicapped by insufficient data and poorly understood RNase P mechanisms.  
 The divergent evolution of the RPR into type-M and type A is best characterized by the loss of 
structure. Archaeal type-A RPR is similar to bacterial ancestors but is distinguished by the absence of 
P18, P13, and P14 regions (Fig. 1.2). Type A has a larger, conserved P12 structure and is identified as 
the ancestral structure class for type-M RPR. Type M is distinguished by a significant rearrangement of 
the cruciform (P7-P11) and the absence of everything distal to P15. A consequence of these deletions is 
the disappearance of P6, and the disappearance of RNA structures responsible for substrate recognition 
(Fig. 1.2) [34]. Consistent with RNA world predictions [44], type M RNA contains no additional RNA 
structural elements that could compensate for the deleted RNA.    
  Despite distinct intramolecular interactions and RNA activity between the domains of life, there 
seems to be no correlation between the number of RPPs and the RPR type. This allows the possibility 
for protein structure to function examination. Currently, the only structural data that exists for M-type 
RPP21-RPP29 comes from homology modeling so our research is aimed at generating a high resolution 
model of this pivotal complex, which likely represents a discrete step toward modern protein based 
biology. 
 
Figure 1.1. The RNase P ribozyme catalyzes hydrolysis of the 5' RNA leader sequence from precursor tRNA. The 
mechanism requires divalent ions and a protein cofactor. The protein cofactors vary in number and function across the 
domains of life; however the RNA subunit is thought to be responsible for directly mediating hydrolysis. Figure adapted 
from ref [9].
 Figure 1.2. The RNase P RNA has unique and conserved features across the domains of life. Helices are designated P1-18. (A) The 
predicted RPR from Bacteria (E. coli is shown) is the largest and most complicated RNA subunit. (B) The predicted secondary structure 
for archaeal type A RPR retains many of the structural elements found in Bacteria, but some intramolecular contacts have been lost. (C) 
The predicted secondary structure for eukaryotic RPR bears structural features similar to archaeal type-M orthologs. (D) Predicted 
archaeal type M RPR secondary structure is simplified from ancestral forms by the loss of P16/P17 regions and a diminished cruciform 
structure. Figure adapted from ref [45]. 
B A 
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 Figure 1.3. In vitro assays have been performed that demonstrate RPR alone catalysis. (A) As opposed to archaeal type-A, 
type-M RPR is only capable of cleaving ptRNA substrates if they are covalently attached. (B) The extent of RPR-ptRNA 
self-cleavage increases as ion concentration increases. The band labeled L represents the 5’ ptRNA leader sequence, and the 
band labeled R represents the tRNA and RNR. Figure adapted from ref [11]. 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.4. (Left) The RNP complex is composed from an intricate array of protein-protein, protein-RNA, and RNA-RNA 
interactions. (Right) An experiment was performed with Pfu that demonstrates how various RNP compositions affect the 
ribozyme activity. A (+) indicates that the particular RPP was present and a blank indicates the absence of a particular RPP. 
RPR∆64-222 is the C domain of the wt RNR. Figure adapted from ref [40]. 
 Figure 1.5. Sequence alignment for RPP29 from various organisms. Red columns indicate a protein residue invariant in each 
of organisms, and outlined columns represent a conservation of residues character (e.g. polar, non-polar, acidic, or 
hydrophobic). Aligned sequences are form Pyrococcus furiosus (NCBI entry NP_579545), Pyrococcus horikoshii 
(NP_143607), Pyrococcus abyssi (NP_126024), Methanobacterium thermoautotrophicum (10QK_A), Methanosarcina 
barkeri (YP_303669), Halobacterium sp. (NP_280464), Thermoplasma acidophilum (NP_394719), Methanococcus 
jannaschii (NP_247439), Methanococcus marapaludis (YP_001549311), Methanococcus vannielii (YP_001323236), 
Archaeoglobus fulgidus (1TSF_A), Saccharomyces cerevisiae (NP_009816), Schizosaccharomyces pombe (NP_588479) 
and Homo sapiens (NP_006618). 
 
 
 
 Figure 1.6. Sequence alignment of RPP21 from various organisms. Red columns indicate a protein residue conserved in 
each of organisms, and outlined columns represent a conservation of residues character (e.g. polar, non-polar, acidic, or 
hydrophobic). The characters that appear above the sequences refer to likely secondary structures. Aligned sequences are 
form Pyrococcus furiosus (NCBI entry NP_579342), Pyrococcus horikoshii (NP_143456), Pyrococcus abyssi 
(NP_126253), Methanobacterium thermoautotrophicum (NP_276730), Methanosarcina barkeri (NCBI_entry YP_304815), 
Halobacterium sp. (NP_279631), Thermoplasma acidophilum (NP_393654), Methanococcus jannaschii (NP_247957), 
Methanococcus marapaludis (YP_001549778), Methanococcus vannielii (YP_001322736), Archaeoglobus fulgidus 
(NP_068950), Saccharomyces cerevisiae (NP_012280), Schizosaccharomyces pombe (NP_596472) and Homo sapiens 
(NP_079115). 
 Figure 1.7. Ribbon diagram of the RPP21-RPP29 complex from Pfu. The alpha helices of both proteins compose the dimer 
interface. The structure was solved with NMR.  Figure adapted from ref [43]. 
 
NMR Spectroscopy 
 Nuclear Magnetic Resonance (NMR) spectroscopy is the primary biophysical method employed 
in this study. As opposed to X-ray crystallography, NMR is preferred for several reasons. 1) NMR is 
obtained from molecules in solution, as opposed to in crystals, where the conformation may deviate 
from the molecule's biologically relevant form. 2) NMR can provide information about molecular 
dynamics. 3) NMR can be used to observe molecular complexes with weak binding affinities, which 
may not be able to form when crystallized due to conformational bias of crystallization conditions.   
 The theory behind NMR can be interpreted with either classical or quantum mechanics. In 
quantum mechanics, every particle can be described by a set of quantum numbers. The nuclear spin 
quantum number is especially relevant for NMR. In principle, each atom in a molecule has a resonance 
energy and can be excited with the use of electromagnetic energy [46]. The resonance energy of each 
nucleus can be identified, and its position with regard to nearby atoms can be extrapolated (Fig. 1.9).     
 To deduce a structure from NMR spectroscopy many different experiments are performed. The 
first step in a typical procedure is to assign a resonance frequency to each of the 1H, 13C and 15N atoms 
of the protein. Next, a series of NMR experiments are performed to determine how far each proton is 
from other protons in the molecule. Then, using distance and torsion angle restraints, a computer 
program can calculate a set of structures consistent with the input constraints.    
1D spectra: Because resonance frequencies for different types of nuclei are very different, a 1-
dimensional spectrum only reports the resonance energies (frequencies) of one type of nucleus; for 
proteins typically 1H (Fig 1.9). Though simple, signal dispersion is a useful metric to determine how 
well a protein is folded. From a 1D spectrum, many important experimental variables can be optimized: 
protein concentration, temperature, buffer conditions, and sample purity.   
Heteronuclear Single Quantum Coherence (HSQC): An HSQC reveals the through-bond correlation 
between different nuclei, like 1H and 15N. This experiment is very versatile, as each type of nucleus 
(e.g. C, N, or H) can be selectively excited, and the transfer of resonance frequency can be easily 
controlled (Fig 1.10). HSQC and similar techniques allow researchers to determine the resonance 
assignment for each atom along a peptide backbone.  
Heteronuclear NOE: The Nuclear Overhauser Effect (NOE) involves the through-space transfer of 
magnetization from one nucleus to another. The magnitude of the NOE depends on the distance 
between cross-relaxing nuclei, and on the timescale of their motion. The goal of the heteronuclear NOE 
experiment is to measure how two bonded atoms, with fixed internuclear distances, are moving 
compared to others. The data collected from the experiment are presented as the ratio between the 
intensities of signals recorded in the absence and presence of the NOE, and ratio’s magnitude reflects 
how fast a particular pair of nuclei is moving compared to the natural tumbling of the protein (Fig. 1.8). 
 
 
Fig 1.8. Heteronuclear 1H-15-N Heteronuclear NOE values for backbone amides in a protein. The y-axis is a measurement of 
the NOE, and reflects the degree of order. Lower NOE values indicate more motion on the ps-ns timescale.   
 
 
              
Figure 1.9. An NMR spectrometer measures an oscillating current that decreases with time. (A) FID is the Free Induction 
Decay of transverse magnetization (B) The FID is reinterpreted via a Fourier transform to give a series of proton signals. 
The amide protons in a protein resonate in the 6-10 ppm range. 
 
 
 
 
 
 
 
 
 
 
 
 
 
 
Figure 1.10. Correlation NMR experiments are a method for viewing correlations between different nuclei in the protein. 
(Left) An HNCACB experiment displays peaks for 13C nuclei that are correlated to nearby protons. (Right) The pink arrows 
on the molecule show how magnetization is transferred between the protein backbone and sidechain. The bottom figure 
shows how an HNCACB spectrum is arranged with an 15N-1H HSQC to create a three dimensional graphic.     
 
 MATERIALS AND METHODS 
Protein Expression 
Each of the proteins, RPP21 and RPP29, were independently over-expressed in competent E. coli cells. 
The RPP21 construct was cloned into the Nco1 and BamH1 restriction sites a pET-15b plasmid 
(provided by J.W. Brown at NCSU), and the RPP29 construct was cloned into the Nde1 and BamH1 
restriction sites of a pLANT-2b plasmid (provided by J.W. Brown at NCSU, kanamycin resistant) (Fig. 
2.1). Plasmid transcription is controlled by a lactose, negative inducible, operon. The pET-15b plasmid 
was transformed into Rosetta DE3 (chloramphenicol and carbenicillin resistant) via electroporation, 
and the pLANT-2b plasmid was transformed into BL21-DE3 (chloramphenicol resistant, rare tRNAs) 
via electroporation. The bacteria were inoculated onto 3:5, agar (15g/L): Lysogeny Broth (LB) with the 
appropriate antibiotics (30 mg/L kanamycin, 50 mg/L carbenicillin, 34 mg/L chlormaphenicol). The LB 
culture plates were incubated for 10-12 hours at 35ºC, after which a single colony was inoculated into 
100 mL of LB with the appropriate antibiotics. The 100 mL culture was incubated for 10-12 hours at 
35ºC. Afterward, 10 mL of this overnight culture was inoculated into 1 L of LB. The 1 L culture was 
grown until 0.6<OD280<0.8. While in this target range the bacteria were induced with 1 mM Isopropyl 
β-D-1-thiogalactopyranoside (IPTG). The Rosetta cells also required 50 µM ZnCl2 for adequate 
overexpression of RPP21, a zinc-binding protein. The cultures were allowed to grow for 10-12 hrs 
before centrifugation (JS-4.2 rotor, 4,500 g, 30 min). The pelleted cells were stored at -4ºC. All LB 
mediums were autoclaved before use.       
Expression of Isotopically Labeled RPP29 
 When growing 15N, 13C-labeled RPP29, the 1 L LB medium was replaced with minimal media. 
Preparation of M9 minimal media: 200 mL of 50 mM Na2HPO4, 25 mM KH2PO4, 10 mM NaCl, 20 
mM 15NH4Cl combined with 750 mL of 1M MgSO4, 20 mM 13C-dextrose, 1M CaCl2. The growth 
 medium was autoclaved, then 10 mL of Gibco Basal Eagle Vitamin mix and antibiotics (1 mM) were 
added.  10 mL of bacteria culture (OD600 = 1.0) were inoculated into the M9 minimal media and the 
procedure for protein expression was followed. 
Protein Purification and Chromatography 
RPP29: From a 1 L culture, pelleted cells were resuspended in 25 mL of buffered 25 mM Tris, pH 7.5, 
25 mM NaCl, 0.1 mM PMSF, 1 mM EDTA. The cells were lysed on ice via sonication (5 min, 5 sec 
pusles, 2 sec int., 65 W)x2. After centrifugation (SS-34 rotor, 26,892 g, 15 min), the supernatant was 
decanted and the pellet was resuspended in 25 mL of buffered 7 M urea, 25 mM Tris, pH 7.5, 10 mM 
DTT, 1 mM EDTA (resuspension buffer). The resuspended lysate was centrifuged (SS-34 rotor, 26,892 
g, 15 min) and filtered (0.1 micron), then loaded onto a 5 mL cation exchange column equilibrated with 
25 mL of resuspension buffer. The protein was eluted using fast protein liquid chromatography (FPLC) 
with an eluent gradient of 0 mM NaCl to 2M NaCl. The eluate fractions containing RPP29 were pooled 
and extensively dialyzed against buffered 10 mM Tris, pH 6.7, 10 mM NaCl, 0.02% NaN3, 0.03 mM 
ZnCl2 (NMR buffer). The protein was concentrated down to 0.5-0.75 mL and stored at -4ºC. 
RPP21: From a 1 L culture, pelleted cells were resuspended in 25 mL of buffered 25 mM Tris, pH 7.5, 
25 mM Kcl, 5 mM imidazole, 6M guanidinium-HCl (lysis buffer) and lysed on ice via sonication [5 
min, 5 sec pusles, 2 sec int., 65 W]x2. The lysate was centrifuged [SS-34 rotor, 26,892 g, 15 min], and 
the supernatant was filtered (0.1 micron) and loaded onto 5 mL metal chelating column (Ni2+) 
equilibrated with 25 mL of lysis buffer. The protein was eluted using FPLC with a gradient from 50 
mM imidazole to 0.5 M imidazole. The eluate fractions were pooled and extensively dialyzed against 
buffered 10 mM Tris, pH 6.7, 10 mM NaCl. The (His)6 tag was removed via TEV protease [1:30, 
RPP21:TEV]. Optimal cleavage was achieved at room temperature in 10 mM Tris, pH 6.7, 10 mM 
NaCl. The TEV, (His)6 tag, and uncleaved protein were separated with a second Ni2+ column. RPP21 
 was washed off the column with 10 mL of buffered 25 mM Tris, pH 7.5, 25 mM KCl, 50 mM 
imidazole, 8M urea, and extensively dialyzed against (10 mM Tris, pH 6.7, 10 mM NaCl, 0.02% NaN3, 
0.03 mM ZnCl2). The purified protein was concentrated down to 0.5-0.75 mL and stored at -4ºC. 
NMR Spectroscopy  
Sample Preparation 
 To prepare sample of the RPP21-RPP29 complex in which RPP29 was uniformly labeled, the 
proteins were dialyzed into the same buffer (10 mM Tris, pH 6.7, 10 mM NaCl, 0.02% NaN3, 0.03 mM 
ZnCl2) and the unlabeled protein (RPP21) was prepared in excess of the labeled protein (RPP29) 
(1.2:1). DSS was then added to the sample (5x[protein]) and the proton concentration was diluted with 
D2O (10% v/v). The NMR sample was prepared at 0.6-0.8 mM. 
Data Acquisition 
 All NMR spectra were acquired from a 600-MHz Bruker Avance DRX spectrometer equipped 
with cryogenically cooled triple-resonance pulse-field gradient probes. Preliminary 1D and 2D (15N-
1H) spectra were recorded at 25ºC, 37ºC, and 55ºC. Subsequent spectra were all acquired at 55ºC. The 
1H, 15N, 13C resonance assignments for free RPP29 were obtained from data collected in the following 
experiments: 15N-1H HSQC, HNCO, HNCA, CBCA(CO)NH, and HNCACB [46]. Another 15N-1H 
HSQC was collected from a sample containing [15N] RPP29 and unlabeled RPP21. The last experiment 
performed was a heteronuclear {1H}-15N NOE on free RPP29. All NMR spectra were processed and 
analyzed with NMRPipe [47], NMRView [48], and CARA (Computer Aided Resonance Assignment 
[49]).   
 
  
 
Figure 2.1. (Left) Map of the pET-15b plasmid vector [50]. Mja RPP21 was cloned into sites Nco1 (5’) and BamH1 (3’) 
(Right) pLANT-2b plasmid vector [51]. Mja RPP29 was cloned into sites Nde1 (5’) and BamH1 (3’) [8]. 
 
 RESULTS 
RPP29 is over-expressed in E. coli 
 The pLANT-2b plasmid that was transformed and expressed in BL21(DE3) cells yields 30-50 
mgs of RPP29 per liter of LB. The produced protein was concentrated in the insoluble fraction of the 
cell lysate, perhaps due to the formation of inclusion bodies, and was resuspended in denaturing 
conditions (7M urea). Based on the pIs of constituent amino acids, the unfolded protein has a predicted 
pI of 9.6 so at pH 7, the majority of RPP29 in solution is expected to be cationic. A 5 mL SP Sepharose 
cation-exchange column (GE Healthcare) was used to isolate the protein, which eluted in 200 mM 
NaCl. RPP29 was easily resolved from most other protein eluates. When refolding the protein by 
dialysis into buffer without urea, white precipitation was observed. SDS-PAGE confirmed the 
precipitate to be contaminating protein. The precipitate was separated via centrifugation and pure 
RPP29 was obtained (Fig. 3.1).              
RPP21-(His)6 is over-expressed in E. coli 
 The pET-15b plasmid encoding the His6-RPP21 fusion construct with a TEV cleavage site 
(…HH-NLYFQ/G-RPP21) was transformed and expressed in Rosetta, yielding 60-80 mgs of RPP21 
per liter of LB culture. The protein eluted from the Ni2+ column (GE Healthcare) in 125 mM imidazole. 
The protein was refolded via dialysis into non-denaturing buffer; however, Zn+ was excluded from the 
buffer because it interferes with the TEV protease. The (His)6 tag was successfully removed after 24 
hrs of digestion (Fig. 3.1). The Ni2+ chelating resin binds histidine so cleaved RPP21 poorly binds to 
the column and could be obtained after washing the column. The isolated and cleaved protein contained 
an additional glycine residue at the N-terminus, but it proved to be inconsequential during dialysis 
refolding.    
 
 Purification of RPP21 and RPP29
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Figure 3.1. (A) The red line on the chromatogram represents the concentration of NaCl in the column. When the 
concentration of salt reaches 0.2 M (10% buffer B), RPP29 begins to elute (the largest peak). The blue line is the UV 
absorbance of eluting material and the dashed red lines are eluate fractions. Beneath the chromatogram (C) is an SDS-PAGE 
gel showing the stages of RPP29 purification. Lanes: (1) soluble fraction after lysis (2) SP column load-on (3) column flow 
through (4) column wash (5-12) column eluate fractions 4-11 (13) molecular weight ladder. (B) The red line represents the 
concentration of Imidazole in the Ni2+ column. The blue line represents the UV absorbance of eluting material and the 
dashed red lines are the eluate fractions. Beneath the chromatogram are SDS-PAGE gels. (D) Stages of RPP21 purification. 
1) column load on 2) column flow through 3) column wash 4)-BLANK- 5) protein eluate #3 6) protein eluate #11 7) 
molecular weight ladder. (E) TEV cleavage of His tag 1) molecular weight ladder 2) RPP21-(His)6 3) RPP21-(His)6 w/ TEV 
in Zn2+ 4) RPP21-(His)6 w/ TEV no Zn2+, 4ºC 5) RPP21-(His)6 w/ TEV no Zn2+, 25ºC. (F) Purified protein 1) RPP21/RPP29 
2) molecular weight ladder 
 
 
 
 
 
 NMR spectroscopy of free RPP29 
 Two-dimensional 1H-15N correlated NMR spectra were acquired from unbound RPP29 at three 
temperatures; 25ºC, 37ºC, and 55ºC (Fig. 3.2). At 25ºC, the spectrum linewidths were very broad and 
few resolved peaks could be discerned from the spectrum. Additionally, the signal to noise ratio (S/N) 
was worse than that observed in other spectra (37ºC and 55ºC). The poor quality of the spectrum was 
likely due to semi-aggregation. At 37ºC, the linewidth had improved, and more peaks could be 
resolved. The highest quality spectrum was obtained at 55ºC; with 130 identifiable spin systems and 
the narrowest linewidths. The S/N was also vastly improved. The triple resonance experiments were 
performed next. The NMR spectra (HNCO, HNCA, CBCA(CO)NH, and HNCACB) were recorded 
over a 2 day period. 
 CARA was used to make the resonance assignments (Fig. 3.3). Of the 95 amino acids that 
compose RPP29, 55 could be assigned (residues 14-24, 26-36, 43-46, 48-54, 56-65, 68-77, and 95). 
With the exception of the C-terminal tyrosine, all of the identified backbone resonances are located 
within the core sequence of the protein. The Sm-like fold expected for RPP29 is characterized by a 
series of anti-parallel beta strands and alpha helices at both termini. The C-terminal alpha helix is 
expected to form between residues 74-86; however, no chemical shifts were observed from that region. 
This suggests that the alpha helix may only form upon binding of RNA or RPP21. Similarly, the 
absence of identifiable signals from the N-terminus is indicative of ill-defined structure for that region 
of the protein. 
 The 1HN, 13Cα, 13Cβ, and 15N chemical shifts from assigned backbone resonances were compared 
to chemical shifts expected from random coil peptides. Similar and consecutive deviations from the 
expected random coil value were interpreted as secondary structure. The value of the deviation was 
used to predict whether each residue adopts an alpha helical or beta sheet structure. Consistent with an 
 Sm-like fold and homology modeling, the data predicted a beta sheet, followed by an alpha helix, then 
four more beta sheets (Fig. 3.4).  
 The {1H}-15N NOE revealed that the core residues of unbound RPP29 were rigidly structured. 
NOE values close to 1 imply a high degree of structure, whereas smaller or negative values imply a 
high degree of flexibility. Most of the assigned resonances had a value of 0.8. The only residue with a 
distinctly lower NOE value was tyrosine-95, which should be expected from a highly disordered area 
(Fig. 1.8).  
Spectral perturbations of RPP29 in solution with RPP21  
 Acquiring NMR spectra from isotope labeled RPP29 in solution with unlabeled RPP21 proved 
to be troublesome. Repeated experiments produced similar spectra with irregular lineshapes and a noise 
ridge in the 1H domain (Fig 3.5). I was not able to determine where or how well RPP21 bound to 
RPP29, but there are clear perturbations between the bound and unbound RPP29 spectra. The most 
Intriguing perturbations occurred within the β5 strand (residues 68-74), which lost most of the unbound 
amide signals (Fig 3.5). This region was the prominent exception, as signals appeared for nearly every 
assigned resonance. It was common to observe an amide signal overlapping an unbound peak while 
another peak was observed in the adjacent area (Fig. 3.6). This observation is most likely due to an 
inhomogeneous mixture of RPP29 folding conformations; unbound and otherwise. Apart from residues 
68-72 and 74, only three other assigned resonances were conspicuously changed, while at least five 
new signals were observed.    
 
 
  
Figure 3.2. Overlay of RPP29 HSQC spectra collected at 25ºC (black), 37ºC (blue), and 55ºC (red). The number of signals 
observed are very similar at each temperature, however the quality of the spectrum improves with increased temperature. 
The peaks from the red spectrum are narrowest and the best dispersed. 
 
 
 
 
 
  
Figure 3.3. (Left) protein amides can be identified 
through comparisons with nearby chemical shifts. Each 
HNCACB strip represents the 13C chemical shifts that 
would appear in the third dimension for a given 1H-15N 
HSQC peak. (Above) Backbone amide resonance 
assignments of free RPP29. The numbers represent the 
numerical position of residues within the protein 
sequence. 
  
Figure 3.4. A Chemical Shift Index (CSI) displays how the resonance frequencies of nuclei of each residue differs from the 
random coil value. The difference is represented as a color; red (alpha helix), blue (beta sheet), or gray (random coil). Above 
the CSI is the Mja RPP29 sequence and expected secondary structure from sequence alignment. This information is used to 
predict secondary structure in solution. 
 
  
Figure 3.5. Overlay of NMR spectra collected from RPP29 (red) and RPP29 in solution with RPP21 (black). There are a 
few perturbations between the spectra. 
 
Figure 3.6. Close up view of the RPP29 (red) and RPP29 in solution with RPP21 (black) overlay. Small, but perceptible 
signals are observed from the RPP29/RPP21 spectrum that overlap with signals from the RPP29 spectrum. This observation 
indicates that some free RPP29 exists in the RPP29/RPP21 sample. 
 DISCUSSION 
RPP21 deviates from expected behavior  
 Initial attempts to purify RPP21 were inspired by its expected isoelectric point, pI, of 10.6. Our 
expectation was that the cationic RPP21 could be easily purified with cation-exchange 
chromatography; however, successive trials resulted in no binding to the negatively charged SP resin. 
Similar preparations have been successful [34], however the preparations were performed from a 
contiguous expression of the RNase P holoenzyme, as opposed to our independent expression of each 
RPP. Other studies that have required isolated protein, often used RPP21 from type-A organisms, and 
while the expected pIs are all similar, there are significant deviations between Mja and Pho/Pfu in the 
locations of non-polar and polar amino acids. No single factor could be identified as causing the 
observed deviations. Ultimately, purification was managed by cloning a poly-Histidine tag with TEV 
site to the N-terminus of the protein.              
Characterization of RPP29 
 At the current stage of structural study I am not able to generate a three dimensional model, 
though several structural motifs have been identified. Our results are mostly consistent with secondary 
structure predictions made from homology modeling. The series of anti-parallel beta sheets observed in 
homologous proteins form a beta barrel structure; however there was a peculiar gap in the RPP29 
resonance assignments expected for the β2/β3 structural elements. Without further structural restraints, 
this region remains largely abstruse. The peaks assigned to the β5 strand (residues 68-75), which were 
either diminished or unobserved in the RPP29/RPP21 spectrum, may be evidence for deviations from 
the expected structure. Structural studies of PhoRPP29 and PfuRPP29 [52, 53] report that the β2 strand 
and terminal α helices compose the heterodimer interface. This provokes the question; does the 
MjaRPP29-RPP21 interface differ from the RPP29-RPP21 interface observed in archaeal type A 
 organisms? The eventual resonance assignment of the RPP29-RPP21 complex will provide a more 
refined picture of RPP29.  
 The HSQC spectra obtained from {15N, 1H}-RPP29/RPP21 was indicative of incomplete/weak 
binding. Small but perceptible signals were observed as matching the underlayed free RPP29 spectrum, 
especially near peaks that have been assigned. This observation may signify a slow exchange between 
conformations, which would have different shielding effects on the amide, or H-bonding events [46].   
 The additional peaks seen in the RPP21/RPP29 spectrum are likely due to discursive 
conformational changes. No doubt the spectra suffered from sample inhomogeneity, but the source 
cause may be an inherently low association constant, KA, for RPP21 and RPP29.  
Conclusion 
 Protocols have been successfully developed for production of RPP21 and RPP29 from the 
archaeon Mja. Subsequent NMR experiments were performed on purified RPP29, and the resonance 
assignment of free RPP29 was completed for over half of the protein. When NMR samples were 
prepared that included RPP21 and labeled-RPP29, the resulting spectra was only modestly different 
than free RPP29. This result likely indicates incomplete binding or protein misfolding, no conclusive 
statement can be made regarding RPP29 structural changes in the presence of RPP21.  
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